Neogen Corp
NASDAQ:NEOG

Watchlist Manager
Neogen Corp Logo
Neogen Corp
NASDAQ:NEOG
Watchlist
Price: 13.07 USD
Market Cap: 2.8B USD
Have any thoughts about
Neogen Corp?
Write Note

Neogen Corp
Total Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Neogen Corp
Total Current Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Total Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
Neogen Corp
NASDAQ:NEOG
Total Current Assets
$540.7m
CAGR 3-Years
-4%
CAGR 5-Years
3%
CAGR 10-Years
10%
Haemonetics Corp
NYSE:HAE
Total Current Assets
$955.9m
CAGR 3-Years
11%
CAGR 5-Years
11%
CAGR 10-Years
6%
ICU Medical Inc
NASDAQ:ICUI
Total Current Assets
$1.3B
CAGR 3-Years
8%
CAGR 5-Years
6%
CAGR 10-Years
11%
Align Technology Inc
NASDAQ:ALGN
Total Current Assets
$2.6B
CAGR 3-Years
2%
CAGR 5-Years
12%
CAGR 10-Years
15%
Lantheus Holdings Inc
NASDAQ:LNTH
Total Current Assets
$1.3B
CAGR 3-Years
86%
CAGR 5-Years
53%
CAGR 10-Years
31%
Merit Medical Systems Inc
NASDAQ:MMSI
Total Current Assets
$1.1B
CAGR 3-Years
33%
CAGR 5-Years
20%
CAGR 10-Years
19%
No Stocks Found

Neogen Corp
Glance View

Market Cap
2.8B USD
Industry
Health Care

Founded in 1982, Neogen Corp. has steadily carved out its niche at the intersection of food safety and animal health, positioning itself as a vital player in agricultural diagnostics. The company's journey began in Lansing, Michigan, where it initially focused on innovative solutions to meet the growing demands of food safety and quality testing. By developing rapid tests for detecting foodborne bacteria and allergens, Neogen tapped into a critical market, addressing the increasing concerns about food safety amidst a complex global supply chain. This foundation in diagnostics set the stage for the growth Neogen would see over the ensuing decades. As Neogen expanded, it strategically diversified its offerings, moving beyond food safety into the broader realm of animal health. This expansion was not merely about developing products; it was about advancing the means by which farms and food producers monitor and ensure the health of their livestock and crops. The company's profits flow from the sale of its diagnostic products, which help minimize risks associated with food contamination and animal diseases. By providing a suite of solutions, from DNA testing for genetic traits and diseases in cattle to disinfectants and rodenticides that maintain farm hygiene, Neogen creates value for its clients by increasing their operational efficiency and safeguarding public health. This strategic blend of food safety and animal health products places Neogen at the heart of modern agricultural and food production systems, where safety and efficiency are paramount.

NEOG Intrinsic Value
14.76 USD
Undervaluation 11%
Intrinsic Value
Price

See Also

What is Neogen Corp's Total Current Assets?
Total Current Assets
540.7m USD

Based on the financial report for Aug 31, 2024, Neogen Corp's Total Current Assets amounts to 540.7m USD.

What is Neogen Corp's Total Current Assets growth rate?
Total Current Assets CAGR 10Y
10%

Over the last year, the Total Current Assets growth was -7%. The average annual Total Current Assets growth rates for Neogen Corp have been -4% over the past three years , 3% over the past five years , and 10% over the past ten years .

Back to Top